Prime Medicine, Inc. (PRME)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Prime Medicine, Inc. (PRME)
Company Performance

Current Price

as of Oct 16, 2024

$3.96

P/E Ratio

N/A

Market Cap

$475.32M

Description

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerPRME
  • Price$3.96+5.04%

Trading Information

  • Market Cap$475.32M
  • Float32.97%
  • Average Daily Volume (1m)2,881,030
  • Average Daily Volume (3m)1,338,438
  • EPS-$2.13

Company

  • Revenue$0.59M
  • Rev Growth (1yr)N/A
  • Net Income-$55.33M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$54.13M
  • EV$491.35M
  • EV/Revenue831.38
  • P/EN/A
  • P/S798.63
  • P/B2.42
Documents